BACKGROUND: Estrogen sulfotransferase (EST) and steroid sulfatase (STS) are known to be involved in in situ estrogen production in estrogen dependent human cancer such as breast cancer, but unknown in prostate cancer. MATERIALS AND METHODS: We first examined whether these enzymes above were expressed and actually involved in estrogen production and metabolism in prostate cancer cell lines (LNCaP, DU-145, and PC-3). We than examined the expression of EST and STS in human prostate cancer tissues obtained from surgery (n = 52) using immunohistochemistry. RESULTS: mRNAs of both enzymes were detected in all prostate cancer cell lines examined, and the synthesis of estrone (E(1)) and estradiol (E(2)) was also confirmed in these cell lines. In addition, STS immunoreactivity was detected in 44 cases (85%) and EST in 39 cases (75%), respectively. CONCLUSIONS: STS and EST are expressed and may be involved in local production and metabolism of estrogens in human prostate cancers. Copyright 2006 Wiley-Liss, Inc.
BACKGROUND:Estrogen sulfotransferase (EST) and steroid sulfatase (STS) are known to be involved in in situ estrogen production in estrogen dependent humancancer such as breast cancer, but unknown in prostate cancer. MATERIALS AND METHODS: We first examined whether these enzymes above were expressed and actually involved in estrogen production and metabolism in prostate cancer cell lines (LNCaP, DU-145, and PC-3). We than examined the expression of EST and STS in humanprostate cancer tissues obtained from surgery (n = 52) using immunohistochemistry. RESULTS: mRNAs of both enzymes were detected in all prostate cancer cell lines examined, and the synthesis of estrone (E(1)) and estradiol (E(2)) was also confirmed in these cell lines. In addition, STS immunoreactivity was detected in 44 cases (85%) and EST in 39 cases (75%), respectively. CONCLUSIONS: STS and EST are expressed and may be involved in local production and metabolism of estrogens in humanprostate cancers. Copyright 2006 Wiley-Liss, Inc.
Authors: Bo Young Suh; Jin Joo Jung; Nahee Park; Cheul Hun Seong; Hee Jung Im; Yeojung Kwon; Donghak Kim; Young Jin Chun Journal: Exp Mol Med Date: 2011-11-30 Impact factor: 8.718
Authors: Amal A El Daibani; Fatemah A Alherz; Maryam S Abunnaja; Ahsan F Bairam; Mohammed I Rasool; Katsuhisa Kurogi; Ming-Cheh Liu Journal: Eur J Drug Metab Pharmacokinet Date: 2021-01 Impact factor: 2.441
Authors: Cameron M Armstrong; Chengfei Liu; Liangren Liu; Joy C Yang; Wei Lou; Ruining Zhao; Shu Ning; Alan P Lombard; Jinge Zhao; Leandro S D'Abronzo; Christopher P Evans; Pui-Kai Li; Allen C Gao Journal: Clin Cancer Res Date: 2020-09-14 Impact factor: 12.531